Yes. The NIH team's story is muddled. They have reported that there was no sign that the people with ME/CFS were fatiguing at a greater rate than the controls in the EFFrT study; tapping rate did not decline over the course of the study. The supposed (average) preference for easy tasks over...
There's some discussion about the use of stem cells here:
USA, Texas - Long Covid stem cell trial - Hope Biosciences
I note that Ren says that the clinic where he was treated with stem cells was rapidly closed down. Also, while he attributes some improvement to the treatment, he continued to...
From Nath's initial comments:
I find that pretty amazing and tone deaf. Despite a substantial budget, enormous resources and a lot of time, the NIH was not able to deliver a study programme with the planned 40 ME/CFS participants. In fact some of the studies had less than 10 ME/CFS...
Maybe, just maybe, in their 'larger clinical trial', they could have some controls who don't get the benefit of any of this very clever requisite multimodal rehabilitation? Who knows, perhaps they would find that some people recover just fine without any inputs?
Maybe, just maybe, in their...
They say they did. And Lucinda Bateman seems to be involved in, at least, the 'structured pacing' trial.
I'm not sure what 'structured pacing' is, but I doubt that it's the only intervention used to prevent post-exertional malaise. Still, I guess it's ok to find out how best to teach newly...
These are the 4 trials:
* stimulants to make people experiencing hypersomnia stay awake :banghead:
* melatonin and light exposure to reset sleep cycles
* 'personalised cardiopulmonary rehabilitation' - exercise, education and social support (supposedly not for people with PEM)
* 'structured...
Maat, I'm not understanding, how does the WHO document relate to the Cochrane Exercise Therapy review?
For people who want to discuss the WHO document itself, with its content on post-Covid-19 condition, there is the WHO News thread.
Well done @Laurie P. That response to your questions is, well, pathetic.
They completely avoid acknowledging that reminding a participant each day of their frailty and asking about whether they want to stop may well have an impact on the person's performance on the task, not least of all a...
Surely that is the reason? There would have been a lot of scrutiny and commentary that might have influenced peer reviewers and editors; possibly even some of the participants may have had something to say.
I'm not a statistician. But, to me, the level of matching at baseline is important when reporting on the difference in mean change. If the placebo group was substantially worse at baseline, then we might think that a decrease in that group might have a lot of 'reversion to the mean' impacting...
The WE&ME Foundation continue to achieve some remarkable things - here, news that they have convinced a medical association to donate the proceeds of their annual doctors' ball event:
Austria: WE&ME Foundation (formerly TEMPI-Stiftung, TEMPI-Foundation)
Thanks yann04, I'll add it to our...
That's remarkable and very positive - that a doctor's association would choose to donate to an ME/CFS research foundation. The foundation must be networking incredibly effectively.
This is the core problem - an organisation that provides a platform for advice on medical treatments, but has no functioning quality control systems. And that's bad for sick people, but also, eventually, bad for Cochrane.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.